Inhibition of cell adhesion protein-carbohydrate interactions
AssigneeThe General Hospital Corporation
InventorsBrian Seed, Gerd Walz
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe General Hospital Corporation
InventorsBrian Seed, Gerd Walz
Estimating the term…
Disclosed is a method of inhibiting the binding of a cell bearing a cell adhesion protein to a molecule or cell bearing a carbohydrate determinant specific for the cell adhesion molecule. The method involves contacting the cell adhesion protein-bearing cell with an inhibitor molecule bearing the carbohydrate determinant. Also disclosed is a method of inhibiting the binding of the first member of a specific binding pair to the second member of the specific binding pair, involving contacting the first member with an antibody which is specific for the first member and which is covalently bonded to a carbohydrate moiety which interferes with the antibody's ability to fix complement and bind an F.sub.c receptor. The methods of the invention may be used, for example, to reduce inflammation.
A method of inhibiting the binding of a cell bearing an ELAM-1 protein to a molecule or cell bearing a sialyl-Le.sup.X determinant, comprising contacting said ELAM-1-bearing cell with an inhibitor molecule bearing said sialyl-Le.sup.X determinant, wherein said inhibitor molecule is an antibody.
A method of inhibiting the binding of a cell bearing an ELAM-1 protein to a molecule or cell bearing a sialyl-Le.sup.X determinant, comprising contacting said ELAM-1-bearing cell with an inhibitor molecule bearing said sialyl-Le.sup.X determinant, wherein said inhibitor molecule is an antibody fusion protein.
Dependencies are inferred from the claim text.